Observational Study of Skull Base Tumors
This is an observational study looking at skull base tumors. Researchers want to understand the biology of these tumors to find new ways to treat them. They will analyze biological samples and genetic material from people diagnosed with a skull base tumor. The study aims to identify new features that could help doctors better categorize tumors, predict how they might respond to treatment, and create more personalized treatment plans. They will also compare primary tumors (first tumors) with recurrent tumors (tumors that come back) to see what changes happen after surgery, chemotherapy, or radiation. The main goal is to track how long patients live (overall survival) over an average of 10 years.
- Study design
- This is an observational study with a planned enrollment of 4000 participants. It is not a treatment study, but rather focuses on understanding the disease.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Patient overall survival will be measured through study completion, an average of 10 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Molecular and Cellular Characterization of Skull Base Tumors
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Paul Gardner, MD · PRINCIPAL_INVESTIGATOR · Associate Professor
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Patient overall survival will be measured and reported.Through study completion, an average of 10 years
There will be one outcome measure: overall survival.